ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 7.6d
Immunosuppression Use: Antirejection Treatment from Transplant
to One Year Post Transplant, 1991 to 2000
Recipients with Pancreas After Kidney (PAK) Transplants

  Year of Transplant
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Transplants 38 29 61 55 66 113 130 158 221 299
Tx with Antirejection Treatments 18 13 27 24 25 38 41 43 55 59
Antibodies Category Usage 72.2% 69.2% 81.5% 66.7% 64.0% 76.3% 61.0% 60.5% 80.0% 59.3%
ALG 44.4% 46.2% 18.5% 20.8% 16.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ATG 0.0% 0.0% 3.7% 4.2% 8.0% 7.9% 9.8% 9.3% 0.0% 1.7%
NRATG/NRATS 0.0% 0.0% 0.0% 0.0% 0.0% 5.3% 7.3% 0.0% 1.8% 0.0%
OKT3 44.4% 46.2% 66.7% 54.2% 48.0% 68.4% 51.2% 48.8% 67.3% 37.3%
Thymoglobulin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.3% 23.6% 25.4%
Zenapax 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.3% 1.8% 1.7%
Simulect 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.1%
Corticosteroids Category Usage 33.3% 46.2% 40.7% 41.7% 48.0% 65.8% 78.0% 69.8% 83.6% 86.4%
Prednisone 0.0% 0.0% 25.9% 25.0% 16.0% 10.5% 14.6% 18.6% 54.5% 27.1%
Methylprednisolone 33.3% 46.2% 14.8% 20.8% 40.0% 60.5% 68.3% 60.5% 32.7% 67.8%

Source: OPTN/SRTR Data as of August 1, 2002.
Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.